Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) and cellular redox enzymes are fundamental components of cellular metabolism, responsible for the majority of ATP production through oxidative phosphorylation (StatPearls, NBK526040). The ETC comprises a series of protein complexes (Complex I through IV) and electron carriers that create a proton gradient across the inner mitochondrial membrane, which is subsequently utilized by ATP synthase to generate energy (NCBI, PMC4761111). Cellular redox enzymes, including superoxide dismutases and glutathione-related enzymes, work in tandem with the ETC to regulate the production and neutralization of reactive oxygen species (ROS), thereby maintaining redox homeostasis (Nature, s41416-018-0298-1). Dysregulation of these systems is central to the pathogenesis of mitochondrial diseases, neurodegenerative conditions such as Parkinson's and Alzheimer's, and various forms of cancer where metabolic shifting occurs (PubMed, 25502153). Pharmacological intervention involves either the inhibition of specific complexes to treat infections (e.g., atovaquone targeting Complex III) and cancer, or the use of antioxidants and metabolic enhancers to mitigate oxidative stress and energy failure in degenerative diseases (PubMed, 10430920; PubMed, 21656513).
Inhibition of electron transfer within complexes I-IV, uncoupling of the proton gradient from ATP synthesis, or modulation of redox-active enzymes to alter cellular oxidative stress levels (StatPearls, NBK526040; PubMed, 10839993).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain (ETC) and cellular redox enzymes (ETC).